조혈모세포이식시 조혈모세포의 체외 증폭능과 생착 소요시간간의 역상관관계

참고문헌 (25)

1. "CD34: structure, biolo-gy, and clinical utility", 87, pp.1~13 (1996)
2. "AC133, a novel marker for human hematopoietic stemand progenitor cells.", 90, pp.5002~5012 (1997)
3. "Flow cytometry for clinical estimation of circulating hematopoieticprogenitors for autologous transplantation in cancer patients", pp.400~9
4. "Autologous transplantation of blood stem cellsmobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting bothgranulocyte and platelet recovery.", 5, pp.663~670 (1996)
5. "Hematopoi-etic cell culture therapies (Part II): Clinical aspects and applications", 14, pp.388~396 (1996)
6. "An analysis of engraftment kinetics as a function of the CD34content of peripheral blood progenitor cell collection in 692 patientsafter the administration of myeloablative chemotherapy", 10, pp.3961~3969 (1995)
7. "Early neutrophil engraftment following autologous BMT pro-vides a functional predictor of long-term hematopoietic reconstitu-tion.", 43, pp.614~621 (2003)
8. "Quantitation of primitive and lineage-committed progenitorsin mobilized peripheral blood for prediction of platelet recovery postautologous transplant", 25, pp.589~598 (2000)
9. "A novel protocol that allows short-term stem cell expansion ofboth committed and pluripotent hematopoietic progenitor cells suit-able for clinical use", 27, pp.715~724 (2001)
10. "TheISHAGE guidelines for CD34+ cell determination by flow cytome-try International Society of Hematotherapy and Graft Engineering", 5, pp.213~226 (1996)
11. "1994 Consensus Conference on Acute GVHD Grading", 15, pp.825~828 (1995)
12. "Chronic graft-versus-host syndrome in man A long-term clinicopathologic study of 20 Seattle patients", pp.204~17
13. "Chronic graft-versus-host disease after allogeneic blood stemcell transplantation", 98, pp.1695~1700 (2001)
14. "Study on the ex vivo ex-pansion characteristics of umbilical cord blood CD34+ cells and mo-nonuclear cells", 24, pp.74~77 (2003)
15. "Ex vivo expansion of CD34+CD38- cord blood cells", 6, pp.93~102 (1997)
16. "Donor-to-donor vari-ability in the expansion potential of human bone marrow cells isreduced by accessory cells but not only soluble growth factors", 24, pp.1484~1493 (1996)
17. "High CD34(+) cell counts decrease hematologic toxicity of autolo-gous peripheral blood progenitor cell transplantation", 91, pp.3148~3155
18. "Comparison of haematological recovery times and support-ivecare requirements of autologous recovery phase peripheral bloodstem cell transplants", pp.277~84, autologous bone marrow transplants and allo-geneic bone marrow transplants Bone Marrow Transplant 1992
19. "Subsets of CD34+ cells and rapid hemato-poietic recovery after peripheral-blood stem-cell transplantation", 13, pp.1922~1932 (1995)
20. "CD34+", CD41a+ cells best predict platelet recovery after autologousperipheral blood stem cell transplantation, 1998, pp.21, 1217~1222
21. "In vitro megakaryocyte expansion in patients with delayed plateletengraftment after autologous stem cell transplantation", 81, pp.192~197 (2002)
22. "Cell adhesion molecule expression on CD34+ cells in graftsand time to myeloid and platelet recovery after autologous stem celtransplantation", 26, pp.10~18 (1998)
23. "The chemokine SDF-1 activates the integrins LFA-1, VLA-4,and VLA-5 on immature human CD34(+) cells: role in transendothelial", stromal migration and engraftment of NOD, pp.2000, 95[DOI]
24. "Analysis of risk factor for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABOincompatibility, and method of T-cell depletion", 7, pp.620~630 (2001)
25. "The pathophysiology of chronic graft-versus-host disease", 79, pp.209~215 (2004)

관련 논문AI추천